Joe Baglio

Raleigh beverage startup raises $376,000, wants more

Posted by Joe Baglio | Nov 4, 2016

A Raleigh based kombucha brewery has raised $375,968, according to a Securities and Exchange Commission filing. Tribucha Inc. filed a Form D on Oct. 19 to raise a total of $475,968. The company said the proceeds will go toward compensation and a streamlined place of production. Kombucha is a variety of fermented, lightly effervescent sweetened black or green tea drinks that are commonly intended as functional beverages for their supposed health benefits, according to Wikipedia. The company launched its line of kombucha drinks 14 months ago and has a customer list of over about 100. It does most of...

CommScope earnings top analysts’ expectations

Posted by Joe Baglio | Nov 3, 2016

CommScope Holding Co. beats analysts’ expectations with earnings of 81 cents per share in the third quarter, according to a filing with the Securities and Exchange Commission Thursday. Net income was $94 million, up from a loss of $81 million [Screen Shot 2016-08-30 at 5.44.19 PM] for the same period last year. Wall Street analysts expected earnings of 71 cents per share. “We are pleased to deliver year-over-year revenue growth and strong bottom-line results, which exceeded our expectations,” said Chief Executive Officer Eddie Edwards in a statement. “Our fiber-to-the-X and wireless technologies were catalysts for this strong performance, especially...

Aerie Pharma files for secondary offering of $125M

Posted by Joe Baglio | Sep 18, 2016

Aerie Pharmaceuticals Inc. filed for secondary offerings of $125 million of shares of its common stock this week, according to a Securities and Exchange Commission filing. Of the offerings, $50 million was sold on Sept. 15. An additional $75 million in shares will be issued on or around Sept. 20 or Sept. 21. Cantor Fitzgerald & Co. is acting as sole book runner for the $75 million public offering and sole manager for the $50 million program. After it reported positive late-stage trial results for a glaucoma therapy called Roclatan, the company decided to raise the funds to run the...

Chapel Hill-based 410 Medical Innovation raises $2.2 million

Posted by Joe Baglio | Sep 7, 2016

A Chapel Hill, North Carolina-based health care company has raised $2.2 million in a private stock placement. The offering aimed to raise $2.5 million, but over $250,000 remains unsold, according to a Securities and Exchange Commission filing. 410 Medical Innovation LLC filed the Form D on Sept. 6. The organization, founded in 2013, did not disclose what it intended to do with the proceeds. The small, privately held company developed a simple solution that allows a health care provider to rapidly deliver fluid to critically ill patients. Sepsis, which arises when the body’s response to infection injures its own...